Global collaboRAtion on CIC-DUX4, BCOR-CCN3, high-grade Undifferentiated round cell sarcoma (URCS) project

Title

Code

GRaCefUl

Type

Osservazionale

Start Year

2019

Status

In Corso

Principal Investigator

051-6365515

marilena.cesari@ior.it

Cesari Marilena, MD

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies

Operational unit that carry out the study

complex unit

Osteoncologia, Sarcomi dell'osso e dei tessuti molli, e Terapie Innovative

Director

Ibrahim Toni, BSc, MSc, MD, PhD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. GRaCefUl.

Thursday 28 August 2025, 15:53

PG0007118_2019_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Global collaboRAtion on CIC-DUX4, BCOR-CCN3, high-grade Undifferentiated round cell sarcoma (URCS) project

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in